Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 290 | 3 | COENZYME Q10//VITAMIN E//TOCOTRIENOL | 42758 |
| 3893 | 2 | FLUORESCENT PROBE 4 DIMETHYLAMINOCHALCONE//FLUORESCENT REPORTER CAPIDAN//UKRAINSKII BIOKHIMICHESKII ZHURNAL | 927 |
| 36001 | 1 | ANTICONVULSIVE PREPARATIONS//BROADENING OF DIAGNOSTIC CRITERIA//CONTROVERSIES WITHIN DIAGNOSTIC CATEGORIZATION | 104 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ANTICONVULSIVE PREPARATIONS | authKW | 303049 | 1% | 100% | 1 |
| 2 | BROADENING OF DIAGNOSTIC CRITERIA | authKW | 303049 | 1% | 100% | 1 |
| 3 | CONTROVERSIES WITHIN DIAGNOSTIC CATEGORIZATION | authKW | 303049 | 1% | 100% | 1 |
| 4 | DISCREPANCY BETWEEN SCIENTIFIC AND PRACTICAL APPLICATION OF DIAGNOSTICS | authKW | 303049 | 1% | 100% | 1 |
| 5 | ENDOGENOUS INTOXICATION SYNDROME | authKW | 303049 | 1% | 100% | 1 |
| 6 | EUROPEAN BRAIN COUNCIL | address | 303049 | 1% | 100% | 1 |
| 7 | FIRST EPISODE DRUG NAIVE | authKW | 303049 | 1% | 100% | 1 |
| 8 | INFUSORIA PARAMECIUM CAUDATUM | authKW | 303049 | 1% | 100% | 1 |
| 9 | MELANCHOLIA AND ATYPICAL DEPRESSIONS | authKW | 303049 | 1% | 100% | 1 |
| 10 | MIDDLE SIZE MOLECULES | authKW | 303049 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Psychiatry | 337 | 21% | 0% | 22 |
| 2 | BIOLOGY, MISCELLANEOUS | 267 | 1% | 0% | 1 |
| 3 | Medicine, Research & Experimental | 201 | 17% | 0% | 18 |
| 4 | MEDICINE, MISCELLANEOUS | 190 | 1% | 0% | 1 |
| 5 | Pharmacology & Pharmacy | 169 | 25% | 0% | 26 |
| 6 | Clinical Neurology | 144 | 17% | 0% | 18 |
| 7 | Pathology | 136 | 11% | 0% | 11 |
| 8 | Biophysics | 26 | 7% | 0% | 7 |
| 9 | Neurosciences | 15 | 10% | 0% | 10 |
| 10 | Physiology | 13 | 5% | 0% | 5 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EUROPEAN BRAIN COUNCIL | 303049 | 1% | 100% | 1 |
| 2 | MINIST PUBL HLTH RUSSIA | 151523 | 1% | 50% | 1 |
| 3 | PSYCHOT EPISODE CLIN 1 | 151523 | 1% | 50% | 1 |
| 4 | MOSCOW PSYCHIAT | 77921 | 3% | 9% | 3 |
| 5 | BRAIN PATHOL | 75759 | 2% | 13% | 2 |
| 6 | MOSCOW SCI PSYCHIAT | 37879 | 1% | 13% | 1 |
| 7 | SPEECH PATHOL NEUROREHABIL | 33670 | 1% | 11% | 1 |
| 8 | ROMODANOV NEUROSURG | 12625 | 1% | 4% | 1 |
| 9 | AFFECT DISORDERS | 1339 | 1% | 0% | 1 |
| 10 | GEN PHYS | 82 | 1% | 0% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 8997 | 10% | 0% | 10 |
| 2 | BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 4455 | 13% | 0% | 14 |
| 3 | ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 3624 | 5% | 0% | 5 |
| 4 | DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE | 3519 | 6% | 0% | 6 |
| 5 | FIZIOLOGICHESKII ZHURNAL | 2524 | 3% | 0% | 3 |
| 6 | KHIRURGIYA | 2126 | 3% | 0% | 3 |
| 7 | VESTNIK AKADEMII MEDITSINSKIKH NAUK SSSR | 1923 | 3% | 0% | 3 |
| 8 | JAPANESE JOURNAL OF PHARMACOLOGY | 1725 | 5% | 0% | 5 |
| 9 | PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1325 | 2% | 0% | 2 |
| 10 | VESTNIK KHIRURGII IMENI I I GREKOVA | 750 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |